Literature DB >> 29581115

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Tatsuro Hirayama1,2, Taiga Miyazaki3,4, Yuka Yamagishi5, Hiroshige Mikamo5, Takashi Ueda6, Kazuhiko Nakajima6, Yoshio Takesue6, Yoshitsugu Higashi7, Yoshihiro Yamamoto7, Muneyoshi Kimura8, Hideki Araoka8, Shuichi Taniguchi9, Yuichi Fukuda10, Yumi Matsuo11, Akiko Furutani12, Kohei Yamashita1, Takahiro Takazono2,4, Tomomi Saijo2, Shintaro Shimamura2, Kazuko Yamamoto2, Yoshifumi Imamura2, Koichi Izumikawa4, Katsunori Yanagihara13, Shigeru Kohno2, Hiroshi Mukae1,2.   

Abstract

A total of 46 clinical isolates of Candida guilliermondii and Candida famata were reidentified genetically, resulting in 27 C. guilliermondii and 12 Candida fermentati strains. The majority of C. guilliermondii strains, but not C. fermentati strains, were isolated from blood cultures. C. fermentati was more sensitive to antifungals, hydrogen peroxide, and killing by murine macrophages than was C. guilliermondii The C. guilliermondii isolates were echinocandin susceptible in vitro but resistant to micafungin in a murine model of invasive candidiasis.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Candida fermentati; Candida guilliermondii; antifungal resistance; echinocandin

Mesh：

Substances：

Year:  2018        PMID： 29581115      PMCID： PMC5971574          DOI： 10.1128/AAC.02528-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  36 in total

1.  Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes.

Authors:  Geoffrey W Thorpe; Chii S Fong; Nazif Alic; Vincent J Higgins; Ian W Dawes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

2.  Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.

Authors:  J Keirns; T Sawamoto; M Holum; D Buell; W Wisemandle; A Alak
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

Authors:  M A Pfaller; D J Diekema; M Mendez; C Kibbler; P Erzsebet; S-C Chang; D L Gibbs; V A Newell
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin.

Authors:  J L Slater; S J Howard; A Sharp; J Goodwin; L M Gregson; A Alastruey-Izquierdo; M C Arendrup; P A Warn; D S Perlin; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

5.  Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov.

Authors:  Ann Vaughan-Martini; Cletus P Kurtzman; Sally Ann Meyer; Eric B O'Neill
Journal:  FEMS Yeast Res       Date:  2005-02       Impact factor: 2.796

6.  Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Hsiao Fang Sun; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  Echinocandin Resistance in Candida.

Authors:  David S Perlin
Journal:  Clin Infect Dis       Date:  2015-12-01       Impact factor: 9.079

8.  Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.

Authors:  Jing-Wei Cheng; Shu-Ying Yu; Meng Xiao; He Wang; Timothy Kudinha; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

9.  Elevated chitin content reduces the susceptibility of Candida species to caspofungin.

Authors:  Louise A Walker; Neil A R Gow; Carol A Munro
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

10.  Differential susceptibility of mitogen-activated protein kinase pathway mutants to oxidative-mediated killing by phagocytes in the fungal pathogen Candida albicans.

Authors:  David M Arana; Rebeca Alonso-Monge; Chen Du; Richard Calderone; Jesús Pla
Journal:  Cell Microbiol       Date:  2007-05-08       Impact factor: 3.715
View more
  2 in total

1.  Clinical Characteristics and Outcomes of Candidemia Caused by Meyerozyma guilliermondii Complex in Cancer Patients Undergoing Surgery.

Authors:  Jingjing Chen; Sufei Tian; Fushun Li; Guoquan Sun; Ke Yun; Shitong Cheng; Yunzhuo Chu
Journal:  Mycopathologia       Date:  2020-09-28       Impact factor: 2.574

2.  Candida guilliermondii as an agent of postpartum subacute mastitis in Rio de Janeiro, Brazil: Case report.

Authors:  Tatiane Nobre Pinto; Alana Kohn; Gisela Lara da Costa; Laura M A Oliveira; Tatiana C A Pinto; Manoel M E Oliveira
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.